{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:40:44Z","timestamp":1790682044118,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.nucmedbio.2014.02.004","type":"journal-article","created":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T21:45:37Z","timestamp":1392673537000},"page":"384-389","source":"Crossref","is-referenced-by-count":7,"title":["Carbon-11 labeled cathepsin K inhibitors: Syntheses and preliminary in vivo evaluation"],"prefix":"10.1016","volume":"41","author":[{"given":"Melissa E.","family":"Rodnick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth M.","family":"Kozloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.H.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Kilbourn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0005","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1515\/hsz-2013-0134","article-title":"Cathepsin K: a unique collagenolytic cysteine peptidase","volume":"394","author":"Novinec","year":"2013","journal-title":"Biol Chem"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0010","first-page":"133","article-title":"Proteases involved in cartilage matrix degradation in osteoarthritis","volume":"2012","author":"Troeberg","year":"1824","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0015","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1468-3083.2011.04436.x","article-title":"Cathepsin k expression in basal cell carcinoma","volume":"27","author":"Ishida","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/mc.20362","article-title":"Cathepsins and osteosarcoma: expression analysis identifies cathepsin K as an indicator of metastasis","volume":"47","author":"Husmann","year":"2008","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0025","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIRCULATIONAHA.106.660340","article-title":"Optical visualization of cathepsin K activity in atherosclerosis with a novel, protease-activatable fluorescence sensor","volume":"115","author":"Jaffer","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0030","first-page":"172","article-title":"Cathepsin K inhibitors: a novel target for osteoporosis therapy","volume":"83","author":"Stoch","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0035","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2008.10.036","article-title":"Non-invasive optical detection of cathepsin K-mediated fluorescence reveals osteoclast activity in vitro and in vivo","volume":"44","author":"Kozloff","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0040","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bone.2011.09.053","article-title":"Clinical utility of 18F-fluoride PET\/CT in benign and malignant bone diseases","volume":"50","author":"Li","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0045","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2967\/jnumed.109.067140","article-title":"Targeting the avb3 integrin for small-animal PET\/CT of osteolytic bone metastases","volume":"50","author":"Wadas","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0050","first-page":"S422","article-title":"Syntheses of radiolabeled cathepsin k inhibitors as potential osteoclast imaging agents","volume":"56","author":"Rodnick","year":"2013","journal-title":"J Labelled Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0055","first-page":"S49","article-title":"Towards the imaging of cathepsin K by PET","volume":"56","author":"Bennacef","year":"2013","journal-title":"J Labelled Compd Radiopharm"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0060","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1021\/jm0613525","article-title":"2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin k","volume":"50","author":"Altmann","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0065","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.nucmedbio.2010.04.164","article-title":"Technetium-labeled cathepsin B inhibitors as molecular imaging agents","volume":"37","author":"Edem","year":"2010","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0070","doi-asserted-by":"crossref","first-page":"e28029","DOI":"10.1371\/journal.pone.0028029","article-title":"Non-invasive imaging of cysteine cathepsin activity in solid tumors using a 64-Culabeled activity-based probe","author":"Ren","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0075","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/cmdc.201300135","article-title":"Synthesis and radiopharmacological characterization of a fluorine-18-labelelled azapeptide nitrile as a potential PET tracer for in vivo imaging of cysteine cathepsins","volume":"8","author":"Loser","year":"2013","journal-title":"ChemMedComm"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0080","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.nucmedbio.2013.01.011","article-title":"177Lu-lLabeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: synthesis, characterization and preliminary in vivo investigation in a pancreatic cancer model","volume":"40","author":"Ogbomo","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0085","unstructured":"Altmann E, Betschart C, Haykawa K et al. Heteroaryl nitrile derivatives, WO 2004\/020441 A1."},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0090","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1016\/j.bmcl.2007.03.028","article-title":"Beta-substituted cyclohexanecorbaxamide cathepsin K inhibitors: modification of the 1,2-disubstituted aromatic core","volume":"17","author":"Robichaud","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0095","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1016\/j.bmcl.2007.09.047","article-title":"Novel Scaffolds for cathepsin K inhibitors","volume":"17","author":"Teno","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.nucmedbio.2014.02.004_bb0100","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1016\/j.bmcl.2008.03.036","article-title":"New chemotypes for cathepsin K inhibitors","volume":"18","author":"Teno","year":"2008","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805114000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805114000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T11:28:56Z","timestamp":1538825336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805114000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0969805114000456"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2014.02.004","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}